February 24, 2018 |
Mitek Sports Launches High Molecular Weight Hyaluronan and Faster Platelet Rich Plasma System
July 10, 2014  | 

Seattle, WA – Mitek Sports Medicine, a leader in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of MONOVISC® High Molecular Weight Hyaluronan, a single-injection treatment for knee pain related to osteoarthritis and the PEAK Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in only 2.5 minutes.[1]

The announcement was made here at the American Orthopaedic Society for Sports Medicine (AOSSM) 2014 Annual Meeting, where Mitek Sports Medicine is featuring innovations along a spectrum of care to help sports medicine specialists provide personalized treatment for joint injuries related to sports and physical activity, as well as degenerative tissue conditions.


MONOVISC is a single-injection hyaluronan treatment that can provide up to six months of pain relief and helps restore joint mobility in patients suffering from pain associated with osteoarthritis of the knee. It is injected directly into the knee to help replace the naturally occuring hyaluronan found in healthy joint fluid, and to cushion, protect and lubricate the knee joint.       Continue>

Page | 1 2
Suggested Articles